ANDA 206036, held by Beijing Tide Pharm. Colesevelam Hydrochloride.
As of Nov 15, 2026, ANDA 206036 (Colesevelam Hydrochloride), held by Beijing Tide Pharm, was first approved by FDA on Oct 14, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 14, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Colesevelam Hydrochloride625MG ยท tablet;oral | Colesevelam Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters